Glycemic Management
Benefits of tubeless closed-loop insulin delivery system sustained at 1 year in young kids
NEW ORLEANS — New data show sustained glycemic improvements and safety at 1 year in very young children with type 1 diabetes who used a tubeless hybrid closed-loop insulin delivery system, researchers reported.
Vitamin D analog does not affect incidence rates of type 2 diabetes in adults
Eldecalcitol, a vitamin D analog, is not associated with a reduced incidence of type 2 diabetes among adults with prediabetes, though it may have a beneficial effect in those with lower insulin secretion, according to study data.
CGM prevents glycemic deterioration in insulin-treated adults with type 2 diabetes
Adults with type 2 diabetes treated with insulin who initiate continuous glucose monitoring better maintain their HbA1c compared with those who do not use CGM, according to study findings.
Diabetes does not shorten cancer survival
SAN DIEGO — Among nearly 4,000 adults with five common types of cancer plus diabetes, diabetes did not affect overall cancer survival, and cancer did not worsen glycemic control, according to study data.
Multicomponent exercise improves cardiometabolic health in those with overweight, obesity
Multicomponent exercise interventions were associated with greater improvements in measures of cardiometabolic health in people with overweight or obesity vs. single-component exercise interventions, according to a meta-analysis.
Insulin pump therapy can be initiated in primary care
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Michael Heile, MD, FAAFP, BC-ADM, a primary care physician and person living with type 1 diabetes, about the benefits of insulin pump therapy for people with type 2 diabetes who use insulin.
Glycemia Risk Index provides new tool for assessing glycemic control with CGM data
A new metric could help simplify continuous glucose monitoring data for people with diabetes and furnish actionable analysis for providers.
40% of new-onset diabetes during COVID-19 remitted at 1 year
Newly diagnosed diabetes was found in 4% of adults admitted to a U.S. hospital with COVID-19 early in the pandemic, and 40.6% of those patients returned to normoglycemia or prediabetes at 1 year, according to study data.
CGM granted breakthrough device designation for in-hospital use
The FDA has granted breakthrough device designation for the use of Dexcom’s continuous glucose monitoring system in the hospital setting, according to an industry press release.
Intensive education improves glycemic outcomes in new-onset type 1 diabetes
Intensive diabetes education with early initiation of continuous glucose monitoring is associated with improvements in HbA1c for children with type 1 diabetes, according to study data.